2020 Insights on US COVID-19 Testing: Symptoms, Asymptomatic and Serology for Immunity - ResearchAndMarkets.com
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Business Wire
DUBLIN--(BUSINESS WIRE)--The "COVID-19 Testing: Symptoms, Asymptomatic, and Serology for Immunity" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering.This new study describes the United States testing for the rapidly evolving COVID-19 pandemic. Testing capability forecasts for PCR assay and Molecular Diagnostics are presented in two-week increments for the next 6 months. The availability of Serological testing is also forecast for the detection of the virus after recovery. All major vendors are included and can be compared with quantities, qualities, and test time.COVID-19 Testing 2020: The Way Forward describes the timelines the virus is likely to take regarding quarantines and successive waves of infection. Successive waves of infection are expected to strike the US population after the shelter in place restrictions start to be lifted. Intensive testing is needed at every stage of COVID-19 disease management. The testing scenarios and the v
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher Co. (NYSE: DHR) is now covered by analysts at Guggenheim. They set a "buy" rating and a $275.00 price target on the stock.MarketBeat
- Australia Environmental Testing Market Report 2024-2031: Rising Adoption Among Government and R&D Laboratories Expected to Generate Growth Opportunities for Market Stakeholders [Yahoo! Finance]Yahoo! Finance
- James Webb Space Telescope best images of 2024 [USA TODAY]USA TODAY
- Medical Devices Technologies and Global Market Outlook 2024-2029, with Profiles of Abbott, BD, Danaher, Medtronic and F. Hoffmann-La Roche [Yahoo! Finance]Yahoo! Finance
- Danaher Co. (NYSE: DHR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
DHR
Earnings
- 10/22/24 - Beat
DHR
Sec Filings
- 12/19/24 - Form 4
- 12/11/24 - Form 8-K
- 11/27/24 - Form 4
- DHR's page on the SEC website